To our knowledge, this is the first study demonstrating the importance of lipid trafficking in progression of prostate cancer in bone and implicating FABP4 as a mediator of adipocyte-tumor cells interactions within metastatic niche. The gene discussed is FABP4; the disease is Familial prostate cancer.